Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus
Journal of Hepatology Oct 06, 2021
Mallet V, Parlati L, Martinino A, et al. - Alcohol use disorders, rather than obesity, were responsible for the majority of the liver burden in this study of data from two hospital-based cohorts of patients with type 2 diabetes (T2D). Such findings imply that patients with T2D should be instructed to drink minimal amounts of alcohol.
In a retrospective, bicentric, longitudinal cohort of 52,066 hospitalized T2D patients [mean age was 64 ± 14 years; 58% were men] from 2010 to 2020, the researchers calculated adjusted hazard ratios of liver disease progression to hepatocellular cancer and/or decompensated cirrhosis.
Alcohol use disorders were linked to all liver-related risk factors and accounted for 57% of liver-related complications.
Non-metabolic liver-related risk factors were responsible for 37% of the liver burden.
T2D control was not linked to the progression of liver disease.
The rate of liver-related complications and of competing mortality were 3.9 and 27.8 per 1000 person-years at risk.
Only in the presence of well-identified risk factors for liver disease progression, such as alcohol use, did the cumulative incidence of liver disease progression exceed the cumulative incidence of competing mortality.
In obese patients, the incidence of hepatocellular cancer was 0.3 per 1,000 person-year, and it increased with age.
The adjusted hazard ratios of liver disease progression for alcoholic liver disease, alcohol use disorders without alcoholic liver disease, non-metabolic liver-related risk factors, and obesity, respectively, were 55.7, 3.5, 8.9, and 1.5.
Alcohol use disorders, non-metabolic liver risk-related risk factors, and obesity were each responsible for 55%, 14%, and 7% of the liver burden, respectively.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries